Search

Displaying results 7531 - 7540 of 7555 in total
  1. Drug

    CPD 923

    go.drugbank.com/drugs/DB05856
    Experimental

    CPD 923 (N-butylgalactonorjirimycin) is an iminosugar and an analogue of ZavescaTM. It shows efficacy in vivo studies, as well as a favourable pre-clinical tolerability profile.

  2. Drug

    Thiorphan

    go.drugbank.com/drugs/DB08626
    Experimental

    A potent inhibitor of membrane metalloendopeptidase (enkephalinase). Thiorphan potentiates morphine-induced analgesia and attenuates naloxone-precipitated withdrawal symptoms.

    Categories: N-substituted Glycines
  3. Drug

    TNP-470

    go.drugbank.com/drugs/DB08633
    Investigational

    O-(chloroacetylcarbamoyl)fumagillol (TNP-470) has been used in trials studying the treatment of HIV Infections, Sarcoma, Kaposi, and Pancreatic Neoplasms.

    Synonyms: O-(chloroacetylcarbamoyl)fumagillol, O-chloroacetylcarbamoylfumagillol
  4. Drug

    SKF-91488

    go.drugbank.com/drugs/DB07106
    Experimental

    Categories: Histamine N-Methyltransferase, antagonists & inhibitors
  5. Drug

    rAAV9-hNAGLU

    go.drugbank.com/drugs/DB18415
    Experimental

    rAAV9-hNAGLU consists of a recombinant AAV9 expressing human alpha-N-acetylglucosaminidase.

  6. Drug

    Nelistotug

    go.drugbank.com/drugs/DB19334
    Investigational

    NCT06062420 (A Platform Study of Novel Immunotherapy Combinations as First-line Treatment in Participants With PD-L1 Positive Recurrent/metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-

  7. Drug

    beta-Escin

    go.drugbank.com/drugs/DB15774
    Investigational

    Mixtures: Reparil Gel N
  8. Drug

    Fluocortolone pivalate

    go.drugbank.com/drugs/DB15777
    Investigational

    Mixtures: ULTRAPROCT N, ULTRAPROCT N
  9. Drug

    XMMME-001-RTA

    go.drugbank.com/drugs/DB17203
    Experimental

    Categories: N-Glycosyl Hydrolases
  10. Drug

    Tralesinidase alfa

    go.drugbank.com/drugs/DB17657
    Investigational

    Tralesinidase alfa is a chimeric fusion protein comprised of recombinant human NAGLU and a modified human insulin-like growth factor 2. It is being investigated for the treatment of mucopolysaccharidosis type IIIB (MPS IIIB), also known ...

    Synonyms: Alpha-N-acetyglucosaminidase-insulin-like-growth-factor-2 fusion protein, Recombinant human alpha-N-acetylglucosaminidase-insulin-like growth factor-2Categories: beta-N-Acetylhexosaminidases